Real-world treatment adherence and dropout across pediatric enuresis subtypes: A retrospective cohort study

Sebastián Tobía-González1, Natalie Barganski1, Melissa Miller1

  • 1Department of Pediatric Urology, Driscoll Children's Hospital, Corpus Christi, TX, USA.

PubMed

Insights

Treatment adherence and dropout in pediatric enuresis vary by subtype. Bowel-bladder dysfunction (BBD) shows higher dropout rates, emphasizing the need for tailored management strategies.

Area of Science:

  • Pediatric Urology
  • Clinical Research
  • Patient Outcomes

Background:

  • Pediatric enuresis is complex, with varied adherence and engagement across subtypes.
  • Limited real-world data exists on adherence and dropout patterns in pediatric enuresis.

Purpose of the Study:

  • To evaluate subtype-specific differences in treatment adherence, dropout, and early response.
  • To analyze a large real-world cohort of pediatric enuresis patients.

Main Methods:

  • Retrospective cohort study of 961 children (5-18 years) with enuresis.
  • Classification into monosymptomatic nocturnal enuresis (MNE), non-monosymptomatic enuresis (NMNE), secondary enuresis (SE), and bowel-bladder dysfunction (BBD).
  • Assessed treatment adherence, dropout at 8-12 weeks, and early response using multivariate logistic regression.

Main Results:

  • Overall treatment success was 43.8%, with 51.4% dropout.
  • Dropout rates were highest in BBD (58.0%) and lowest in MNE (45.0%).
  • BBD independently predicted higher dropout (OR 1.42); lower early response was the strongest predictor (OR 3.24). MNE had the highest early response (53.1%).

Conclusions:

  • Treatment adherence and dropout in pediatric enuresis significantly differ by subtype in real-world settings.
  • Complex phenotypes like BBD are linked to increased dropout, irrespective of early treatment response.
  • Accurate subtype classification, counseling, and follow-up are crucial for improving pediatric enuresis management.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
384
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
569
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
631
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.2K
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
536